Cooling Towers House New Bacteria-Infecting Amoebas
An amoeba is infected with a novel bacterium, CC99. Numerous coccoid bacteria fill the nucleus of the amoeba 48 hours after infection as it begins to rupture. Art/Mary FaroneÂ
Results of a new study published online by Environmental Science & Technology suggest these amoebas infected with bacteria are more prevalent in cooling towers than in natural environments. Sharon Berk of Tennessee Technological University and colleagues sampled 40 cooling towers in hospitals, universities and industries and 40 natural environmentslakes, rivers, creeks and pondsfinding infected amoebas in 22 of the cooling towers and only three of the natural samples.
"The bacteria responsible for Legionnaire's disease use amoebas as a host, as do many related bacteria," said Berk, a TTU biology professor.
The bacteria can then hijack the amoeba's cellular machinery and then multiply profusely. According to Berk, eventually the amoeba swells and bursts like a balloon, releasing the bacteria by the hundreds.
People can contract pneumonia after inhaling Legionella in aerosol drifts from cooling towers, according to a related ES&T article. It is possible that other amoeba-associated microorganisms, such as those found in cooling towers in the study, may be unrecognized causes of other respiratory disease.
Source: Tennessee Technological University   Â
Newsletter
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
